Jasemine C. Chambers

Array ( [id] => 2981799 [patent_doc_number] => 05250431 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-10-05 [patent_title] => 'Alteration of the interaction of a T-cell receptor with a proteintyrosine kinase' [patent_app_type] => 1 [patent_app_number] => 7/759639 [patent_app_country] => US [patent_app_date] => 1991-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5431 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/250/05250431.pdf [firstpage_image] =>[orig_patent_app_number] => 759639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3440144 [patent_doc_number] => 05429922 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-07-04 [patent_title] => 'Composition and method for distinguishing virulent and non-virulent toxoplasma infections' [patent_app_type] => 1 [patent_app_number] => 7/755009 [patent_app_country] => US [patent_app_date] => 1991-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9791 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/429/05429922.pdf [firstpage_image] =>[orig_patent_app_number] => 755009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2993525 [patent_doc_number] => 05347075 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-09-13 [patent_title] => 'Mutagenesis testing using transgenic non-human animals carrying test DNA sequences' [patent_app_type] => 1 [patent_app_number] => 7/711332 [patent_app_country] => US [patent_app_date] => 1991-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3887 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/347/05347075.pdf [firstpage_image] =>[orig_patent_app_number] => 711332 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3489506 [patent_doc_number] => 05470824 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-11-28 [patent_title] => 'Method to treat Kaposi\'s sarcoma' [patent_app_type] => 1 [patent_app_number] => 7/707863 [patent_app_country] => US [patent_app_date] => 1991-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5609 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/470/05470824.pdf [firstpage_image] =>[orig_patent_app_number] => 707863 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3049145 [patent_doc_number] => 05306631 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-04-26 [patent_title] => 'Compositions and method for inhibition of HIV production' [patent_app_type] => 1 [patent_app_number] => 7/685601 [patent_app_country] => US [patent_app_date] => 1991-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 12987 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/306/05306631.pdf [firstpage_image] =>[orig_patent_app_number] => 685601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2974472 [patent_doc_number] => 05256560 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-10-26 [patent_title] => 'Primitive cell colony stimulating factors and lymphohematopoietic progenitor cells' [patent_app_type] => 1 [patent_app_number] => 7/677617 [patent_app_country] => US [patent_app_date] => 1991-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14356 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/256/05256560.pdf [firstpage_image] =>[orig_patent_app_number] => 677617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2893404 [patent_doc_number] => 05244793 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-09-14 [patent_title] => 'TGF-.beta.1/.beta.2: a novel chimeric transforming growth factor-beta' [patent_app_type] => 1 [patent_app_number] => 7/667246 [patent_app_country] => US [patent_app_date] => 1991-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 3 [patent_no_of_words] => 6991 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/244/05244793.pdf [firstpage_image] =>[orig_patent_app_number] => 667246 [rel_patent_id] =>[rel_patent_doc_number] =>)